il tango della pcos

Nel 2025 ricorre il 90º anniversario della pubblicazione del report di Irving Freiler Stein
e di Michael Leventhal intitolato“Amenorrea associata a ovaie policistiche”.
Il report “Stein e Leventhal” del 1935 è stato sia fondamentale che rivoluzionario.

The Group

The Experts Group on Inositol in Basic and Clinical Research and on PCOS
(EGOI-PCOS) brings together several international personalities, researchers and
opinion leaders, skilled in the field of inositol physiology and therapy, with the aim
to discuss and share scientific contents relating to their own expertise in the field.

UPDATE

EGOI joins the Alliance for Health Promotion,
a non-governative organization affiliated with the World Health Organization (WHO)

Mission

The Experts Group on Inositol in Basic and Clinical Research,
and on PCOS (EGOI – PCOS) was conceived to address and clarify
some important issues concerning the physiological role and the hypothetical
use of Inositols in a number of biological and medical fields, including gynecology,
reproduction, cancer, neurology, metabolic and endocrinological disorders.

Publications

This section collects the most significant scientific contents of EGOI members
concerning the use of inositols alone or in association, both in basic research
and for clinical application.

Activities

The most significant activities/events about the use of inositols,
alone or in association, both in basic research and in clinical practice
are reported in this section.

Experts

Countries

Publications

Recent updates

Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome

Oct 2016

Authors: Anshu Gupta, Daniela Jakubowicz, and John E. Nestler

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials

Sep 2016

Authors: Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas, and Fabio Facchinetti

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk

Sep 2016

Authors: Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti, and Marialuisa Appetecchia

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator During Weight Loss in Obese Women With and Without Polycystic Ovary Syndrome

Sep 2016

Authors: Kai I Cheang, Sakita N Sistrun, Kelley S Morel, John E Nestler

Myo-Inositol Safety in Pregnancy: From Preimplantation Development to Newborn Animals

Sep 2016

Authors: Nilay Kuşcu, Mariano Bizzarri, and Arturo Bevilacqua

Inositols: From Physiology to Rational Therapy in Gynecological Clinical Practice

Aug 2016

Authors: Vittorio Unfer, Beatrice Orrù, Giovanni Monastra

A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years

Aug 2016

Authors: Saghar Salehpour, Leila Nazari, Sedighe Hoseini, Nasrin Saharkhiz, Fatemeh Ghazi, Mohammad Reza Sohrabi

Myo-Inositol in the Treatment of Teenagers Affected by PCOS

Aug 2016

Authors: Lali Pkhaladze, Ludmila Barbakadze, and Nana Kvashilava

Inositol Induces Mesenchymal-Epithelial Reversion in Breast Cancer Cells Through Cytoskeleton Rearrangement

Jul 2016

Authors: Simona Dinicola, Gianmarco Fabrizi, Maria Grazia Masiello, Sara Proietti, Alessandro Palombo, Mirko Minini, Abdel Halim Harrath, Saleh H Alwasel, Giulia Ricci, Angela Catizone, Alessandra Cucina, Mariano Bizzarri

Spotlight on inositol: the fertility molecule and beyond

Jul 2016

The long-awaited meeting between the two pioneers of Italian-American research that has led to the discovery of its many benefits. Vittorio Unfer and Jhon E. Nestler address the topic on the balance between the two main inositol stereoisomers, myo-inositol and D-chiro-inositol. The importance of the 40: 1 ratio myo- to D-chiro in PCOS treatment.

« Older Entries

Next Entries »

The experts group stats & facts

Experts

Countries

Publications

Recent updates